To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of offering antibody tests to people who are immunocompromised and suppressed, who are unsure whether or not they have generated an immune response to the covid-19 vaccines, or whether they remain immunologically vulnerable and need to shield.
27 January 2022
There are no imminent plans to implement targeted antibody testing for immunocompromised patients. National Health Service clinicians can arrange antibody testing for patients based on their assessment of clinical need. Those with a cancer diagnosis may also be able to access free antibody tests through the National Cancer COVID Survey, which aims to assess levels of protection conferred by antibodies following vaccination or infection in cancer patients.